Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase -: Implications for polymerase translocation and drug resistance

被引:80
|
作者
Marchand, B
Götte, M
机构
[1] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2T5, Canada
[3] McGill Univ, Dept Expt Med, Montreal, PQ H3A 2T5, Canada
关键词
D O I
10.1074/jbc.M304262200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to nucleoside analogue inhibitors of the reverse transcriptase of the HIV-1 often involves phosphorolytic excision of the incorporated chain terminator. Previous crystallographic and modeling studies suggested that this reaction could only occur when the enzyme resides in a pre-translocational stage. Here we studied mechanisms of polymerase translocation using novel site-specific footprinting techniques. Classical footprinting approaches, based on the detection of protected nucleic acid residues, are not sensitive enough to visualize subtle structural differences at single nucleotide resolution. Thus, we developed chemical footprinting techniques that give rise to hyperreactive cleavage on the template strand mediated through specific contacts with the enzyme. Two specific cuts served as markers that defined the position of the polymerase and RNase H domain, respectively. We show that the presence of the next correct dNTP, following the incorporated chain terminator, caused a shift in the position of the two cuts a single nucleotide further downstream. The footprints point to monotonic sliding motions and provide compelling evidence for the existence of an equilibrium between pre- and post-translocational stages. Our data show that enzyme translocation is reversible and uncoupled from nucleotide incorporation and the release of pyrophosphate. This translocational equilibrium ensures access to the pre- translocational stage after incorporation of the chain terminator. The efficiency of excision correlates with an increase in the population of complexes that exist in the pre- translocational stage, and we show that the latter configuration is preferred with an enzyme that contains mutations associated with resistance to nucleoside analogue inhibitors.
引用
收藏
页码:35362 / 35372
页数:11
相关论文
共 50 条
  • [1] Derivatives of Mesoxalic Acid Block Translocation of HIV-1 Reverse Transcriptase
    Bernatchez, Jean A.
    Paul, Rakesh
    Tchesnokov, Egor P.
    Ngure, Marianne
    Beilhartz, Greg L.
    Berghuis, Albert M.
    Lavoie, Rico
    Li, Lianhai
    Auger, Anick
    Melnyk, Roman A.
    Grobler, Jay A.
    Miller, Michael D.
    Hazuda, Daria J.
    Hecht, Sidney M.
    Goette, Matthias
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (03) : 1474 - 1484
  • [2] Trapping HIV-1 reverse transcriptase before and after translocation on DNA
    Sarafianos, SG
    Clark, AD
    Tuske, S
    Squire, CJ
    Das, K
    Sheng, DQ
    Ilankumaran, P
    Ramesha, AR
    Kroth, H
    Sayer, JM
    Jerina, DM
    Boyer, PL
    Hughes, SH
    Arnold, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) : 16280 - 16288
  • [3] Impact of Primer-induced Conformational Dynamics of HIV-1 Reverse Transcriptase on Polymerase Translocation and Inhibition
    Auger, Anick
    Beilhartz, Greg L.
    Zhu, Siqi
    Cauchon, Elizabeth
    Falgueyret, Jean-Pierre
    Grobler, Jay A.
    Ehteshami, Maryam
    Goette, Matthias
    Melnyk, Roman A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (34) : 29575 - 29583
  • [4] Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation
    Goette, Matthias
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1867 - 1877
  • [5] HIV-1 reverse transcriptase inhibitors: Drug resistance and drug development
    Sluis-Cremer, Nicolas
    Ross, Ted
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (15) : 1809 - 1810
  • [6] Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
    Singh, Kamalendra
    Marchand, Bruno
    Kirby, Karen A.
    Michailidis, Eleftherios
    Sarafianos, Stefan G.
    VIRUSES-BASEL, 2010, 2 (02): : 606 - 638
  • [7] HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
    Shafer, Robert W.
    Rhee, Soo-Yon
    Pillay, Deenan
    Miller, Veronica
    Sandstrom, Paul
    Schapiro, Jonathan M.
    Kuritzkes, Daniel R.
    Bennett, Diane
    AIDS, 2007, 21 (02) : 215 - 223
  • [8] A Gripping New Mechanism of Drug Resistance in HIV-1 Reverse Transcriptase
    Schauer, Grant
    Sluis-Cremer, Nic
    Leuba, Sanford
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 498A - 498A
  • [9] NUCLEOSIDE DRUG-RESISTANCE IN HIV-1 REVERSE-TRANSCRIPTASE
    YADAV, PNS
    YADAV, JS
    MODAK, MJ
    NATURE STRUCTURAL BIOLOGY, 1995, 2 (03): : 193 - 195
  • [10] Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance
    Mellors, JW
    Larder, BA
    Schinazi, R
    Deverson, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 92 - 92